Leo Wealth LLC Invests $228,000 in Cigna Group $CI

Leo Wealth LLC purchased a new position in Cigna Group (NYSE:CI) in the second quarter, HoldingsChannel.com reports. The fund purchased 690 shares of the health services provider’s stock, valued at approximately $228,000.

A number of other institutional investors also recently made changes to their positions in CI. Family Legacy Inc. grew its position in shares of Cigna Group by 0.5% in the first quarter. Family Legacy Inc. now owns 6,497 shares of the health services provider’s stock valued at $2,138,000 after purchasing an additional 31 shares during the period. Impact Investors Inc grew its position in shares of Cigna Group by 1.6% in the first quarter. Impact Investors Inc now owns 1,975 shares of the health services provider’s stock valued at $650,000 after purchasing an additional 31 shares during the period. Mission Wealth Management LP grew its position in shares of Cigna Group by 1.5% in the first quarter. Mission Wealth Management LP now owns 2,101 shares of the health services provider’s stock valued at $691,000 after purchasing an additional 32 shares during the period. Westend Capital Management LLC grew its position in shares of Cigna Group by 8.1% in the first quarter. Westend Capital Management LLC now owns 427 shares of the health services provider’s stock valued at $140,000 after purchasing an additional 32 shares during the period. Finally, Financial Network Wealth Advisors LLC grew its position in shares of Cigna Group by 26.8% in the first quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock valued at $53,000 after purchasing an additional 34 shares during the period. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Price Performance

CI stock opened at $301.00 on Friday. The stock has a 50-day moving average price of $294.68 and a two-hundred day moving average price of $309.31. The company has a market cap of $80.35 billion, a PE ratio of 16.43, a price-to-earnings-growth ratio of 0.90 and a beta of 0.45. Cigna Group has a 12-month low of $256.89 and a 12-month high of $358.88. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI) last issued its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. The company had revenue of $67.13 billion for the quarter, compared to analysts’ expectations of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The firm’s quarterly revenue was up 11.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th were paid a dividend of $1.51 per share. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date was Thursday, September 4th. Cigna Group’s payout ratio is currently 32.97%.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares in the company, valued at $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the business’s stock in a transaction dated Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. This represents a 9.49% decrease in their position. The disclosure for this sale can be found here. Insiders own 0.70% of the company’s stock.

Wall Street Analyst Weigh In

CI has been the subject of a number of recent analyst reports. Guggenheim reaffirmed a “buy” rating and issued a $350.00 price objective (down previously from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. TD Cowen raised Cigna Group to a “strong-buy” rating in a research report on Monday, June 23rd. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $371.00 price objective on shares of Cigna Group in a research report on Thursday, June 26th. Wells Fargo & Company boosted their price target on Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a research report on Tuesday. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a research report on Wednesday. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $372.69.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.